Raymond M. Jordt

CIK: 0001960780

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)5 (33.3%)

Derivative conversions

Awards (A)5 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)5 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ALT

Altimmune, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

ALT
Altimmune, Inc.
Jan 31, 2026
Award(A)
Direct
4.6K shares at avg. $3.07$14K
ALT
Altimmune, Inc.
Jan 27, 2026
Exercise(M)
Direct
15.9K shares-
ALT
Altimmune, Inc.
Jan 27, 2026
Tax Payment(F)
Direct
4.2K shares at avg. $6.18$26K
ALT
Altimmune, Inc.
Jan 25, 2026
Tax Payment(F)
Direct
3.9K shares at avg. $5.50$21K
ALT
Altimmune, Inc.
Jan 25, 2026
Exercise(M)
Direct
14.6K shares-
ALT
Altimmune, Inc.
Jan 1, 2026
Tax Payment(F)
Direct
2.5K shares at avg. $3.61$9K
ALT
Altimmune, Inc.
Jan 1, 2026
Exercise(M)
Direct
9.4K shares-
ALT
Altimmune, Inc.
Jul 31, 2025
Award(A)
Direct
1.4K shares at avg. $3.14$4K
ALT
Altimmune, Inc.
Jan 31, 2025
Award(A)
Direct
2.6K shares at avg. $5.18$14K
ALT
Altimmune, Inc.
Jan 27, 2025
Award(A)
Restricted Stock Units
Direct
63.4K shares-
ALT
Altimmune, Inc.
Jan 27, 2025
Award(A)
Stock Options (option to buy)
Direct
183.6K shares-
ALT
Altimmune, Inc.
Jan 25, 2025
Tax Payment(F)
Direct
3.9K shares at avg. $6.98$27K
ALT
Altimmune, Inc.
Jan 25, 2025
Exercise(M)
Direct
14.6K shares-
ALT
Altimmune, Inc.
Jan 1, 2025
Exercise(M)
Direct
9.4K shares-
ALT
Altimmune, Inc.
Jan 1, 2025
Tax Payment(F)
Direct
2.5K shares at avg. $7.21$18K

		Type	Shares	Price		Ownership
Jan 31, 2026	ALT Altimmune, Inc.	Award(A)	4,571	$3.07	$14,033	Direct
Jan 27, 2026	ALT Altimmune, Inc.	Exercise(M)	15,850	-	$0	Direct
Jan 27, 2026	ALT Altimmune, Inc.	Tax Payment(F)	4,229	$6.18	$26,135	Direct
Jan 25, 2026	ALT Altimmune, Inc.	Tax Payment(F)	3,855	$5.50	$21,203	Direct
Jan 25, 2026	ALT Altimmune, Inc.	Exercise(M)	14,600	-	$0	Direct
Jan 1, 2026	ALT Altimmune, Inc.	Tax Payment(F)	2,475	$3.61	$8,935	Direct
Jan 1, 2026	ALT Altimmune, Inc.	Exercise(M)	9,375	-	$0	Direct
Jul 31, 2025	ALT Altimmune, Inc.	Award(A)	1,368	$3.14	$4,296	Direct
Jan 31, 2025	ALT Altimmune, Inc.	Award(A)	2,614	$5.18	$13,541	Direct
Jan 27, 2025	ALT Altimmune, Inc.	Award(A) Restricted Stock Units	63,400	-	-	Direct
Jan 27, 2025	ALT Altimmune, Inc.	Award(A) Stock Options (option to buy)	183,600	-	-	Direct
Jan 25, 2025	ALT Altimmune, Inc.	Tax Payment(F)	3,862	$6.98	$26,957	Direct
Jan 25, 2025	ALT Altimmune, Inc.	Exercise(M)	14,600	-	$0	Direct
Jan 1, 2025	ALT Altimmune, Inc.	Exercise(M)	9,375	-	$0	Direct
Jan 1, 2025	ALT Altimmune, Inc.	Tax Payment(F)	2,485	$7.21	$17,917	Direct

1-15 of 15 transactions

About Jordt Raymond M

Jordt Raymond M (SEC CIK 0001960780) files insider reports with the SEC as Chief Business Officer of Altimmune, Inc. (ALT).

Signal8 holds 8 ownership filings by Jordt Raymond M, all Form 4s, filed between Jan 3, 2025 and Feb 2, 2026. Those filings report 15 transactions, from Jan 1, 2025 to Jan 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jordt Raymond M's filings is in GAITHERSBURG, MD.

Recent filings by Jordt Raymond M

Jan 31, 2026: Grant or award of ALT shares (Form 4, code A).
Jan 27, 2026: Option exercise of ALT shares (Form 4, code M).
Jan 27, 2026: Tax withholding of ALT shares (Form 4, code F).
Jan 25, 2026: Tax withholding of ALT shares (Form 4, code F).
Jan 25, 2026: Option exercise of ALT shares (Form 4, code M).

Other insiders filing for Altimmune, Inc. (ALT)

Arbet-Engels Christophe, Chief Medical Officer
WEAVER GREGORY L, Chief Financial Officer
MENZIUSO RICHARD THOMAS, Principal Accounting Officer
Richardson Linda M, Chief Commercial Officer
Durso Jerome Benedict, President and CEO
Roberts M Scot, Chief Scientific Officer

How to read Form 4 transaction codes